Iatrogenic Disease: Clinical Trials

7 trials for Iatrogenic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 17Completed 5, Not yet recruiting 1, Unknown 1

Follow Iatrogenic Disease: new trials by email Literature Review of Iatrogenic Disease trials Research Report on Iatrogenic Disease

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Inhaled Polymyxin as an Adjunct to Intravenous Therapy in Multidrug Resistant Ventilator-associated Pneumonia in Stroke Patients
Inhaled colistin, Saline - Ventilator Associated Pneumonia ( VAP)
Early Phase 1Not yet recruitingAin Shams University782026-10-102026-10-08
Open Suction Circuit Flushing With Chlorhexidine Decreases Ventilator-Associated Pneumonia: A Quasi-experimental Study
Open tracheal suction system flushing with chlorhexidine - Ventilator Associated Pneumonia
Early Phase 1CompletedMansoura University1362020-05-102022-01-25
Microdosing of BAC ONE to the Distal Lung
BAC ONE administration - Bacterial Respiratory Infections
Early Phase 1CompletedUniversity of Edinburgh142016-05-012020-03-26
Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
Atorvastatin, Placebo - Ventilator-associated Pneumonia, Ischemic Stroke
Early Phase 1UnknownShanghai Minhang Central Hospital1002012-03-012013-02-26
Study of Biotene OralBalance Gel for Oral Care in Critically-Ill Mechanically Ventilated Neonates
Biotene OralBalance® gel, Sterile Water moisten cotton tipped applicator - Ventilator-associated Pneumonia
Early Phase 1CompletedWake Forest University Health Sciences412010-05-012018-09-11
Pravastatin and Ventilatory Associated Pneumonia
Pravastatin - Ventilator Associated Pneumonia
Early Phase 1CompletedUniversity of Thessaly1522008-06-012011-11-30
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
vancomycin or gentamicin, Placebo - Respiratory Infection, Bacterial Resistance
Early Phase 1CompletedStony Brook University472001-12-012013-06-17

Narrower conditions

Pneumonia, Ventilator-Associated (7)  ·  Ischemic Stroke (1)  ·  Respiratory Insufficiency (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Cross Infection (7)  ·  Disease Attributes (7)  ·  Healthcare-Associated Pneumonia (7)  ·  Infections (7)  ·  Lung Diseases (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pneumonia (7)  ·  Respiratory Tract Diseases (7)  ·  Respiratory Tract Infections (6)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)

Interventions

Atorvastatin (1)  ·  Chlorhexidine (1)  ·  Gentamicins (1)  ·  Pravastatin (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Vancomycin (1)

Sponsors

Ain Shams University (1)  ·  Mansoura University (1)  ·  Shanghai Minhang Central Hospital (1)  ·  Stony Brook University (1)  ·  University of Edinburgh (1)  ·  University of Thessaly (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (2)  ·  China (1)  ·  Egypt (1)  ·  Greece (1)  ·  United Kingdom (1)

Top investigators

Beatrice Stefanescu, MD, MS (1)  ·  Kev Dhaliwal, MBChB (1)  ·  Liu ChunYan, MD (1)  ·  Lucy B Palmer, MD (1)

Results publications

PMID 23608625, PMID 24646034, PMID 38111699